SMTL ID : 3qdj.1

The complex between TCR DMF5 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric peptide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

hetero-1-1-1-1-mer

Ligands

1 x ALA- ALA- GLY- ILE- GLY- ILE- LEU- THR- VAL: MART-1(27-35) peptide(Non-covalent)

ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL.1: 33 residues within 4Å: Chain A: M.5, Y.7, E.63, K.66, H.70, T.73, V.76, D.77, T.80, L.81, Y.84, R.97, Y.99, Y.116, T.143, K.146, W.147, A.150, V.152, Q.155, L.156, Y.159, W.167, Y.171 Chain C: Q.30, S.31, N.91, G.93 Chain D: N.30, L.95, S.96, F.97, G.98 28 PLIP interactions: 21 interactions with chain A, 3 interactions with chain C, 4 interactions with chain D Hydrophobic interactions: A:K.66, A:V.76, A:D.77, A:L.81, A:Y.116, A:T.143, A:W.147, A:A.150, A:V.152, A:W.167, C:Q.30, D:F.97, D:F.97 Hydrogen bonds: A:Y.7, A:E.63, A:K.66, A:D.77, A:Y.84, A:Y.99, A:Y.99, A:Y.159, A:Y.171, C:Q.30, C:Q.30, D:N.30, D:S.96 Water bridges: A:R.97 Salt bridges: A:K.146

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Borbulevych, O.Y. et al., TCRs Used in Cancer Gene Therapy Cross-React with MART-1/Melan-A Tumor Antigens via Distinct Mechanisms. J.Immunol. (2011)

Release Date

2011-07-06

Peptides

HLA class I histocompatibility antigen, A-2 alpha chain: A
Beta-2-microglobulin: B
DMF5 alpha chain: C
DMF5 beta chain: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
D

D
E

HLA class I histocompatibility antigen, A-2 alpha chain

Beta-2-microglobulin

DMF5 alpha chain

DMF5 beta chain

Related Entries With Identical Sequence